Under the proposed rule by the Biden administration, anti-obesity drugs such as Ozempic and Wegovy would be covered by Medicare and Medicaid. These are GLP-1 inhibitors, a class of drugs that help control blood sugar levels in individuals with type 2 diabetes. The proposal suggests that these drugs would be covered when used to treat obesity or overweight with at least one weight-related condition. However, this proposal will need to go through the appropriate channels before it becomes official, so please keep an eye on the latest updates regarding this matter. Is there anything else you would like to know?
